MA23907A1 - Procede de fabrication de s(+) etodolac administrable par voie orale - Google Patents

Procede de fabrication de s(+) etodolac administrable par voie orale

Info

Publication number
MA23907A1
MA23907A1 MA24280A MA24280A MA23907A1 MA 23907 A1 MA23907 A1 MA 23907A1 MA 24280 A MA24280 A MA 24280A MA 24280 A MA24280 A MA 24280A MA 23907 A1 MA23907 A1 MA 23907A1
Authority
MA
Morocco
Prior art keywords
etodolac
manufacture
oral administrative
administrative
oral
Prior art date
Application number
MA24280A
Other languages
English (en)
Inventor
Leslie George Humber
Gerald Louis Reuter
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MA23907A1 publication Critical patent/MA23907A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
MA24280A 1995-06-13 1996-06-12 Procede de fabrication de s(+) etodolac administrable par voie orale MA23907A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17195P 1995-06-13 1995-06-13

Publications (1)

Publication Number Publication Date
MA23907A1 true MA23907A1 (fr) 1996-12-31

Family

ID=21690247

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24280A MA23907A1 (fr) 1995-06-13 1996-06-12 Procede de fabrication de s(+) etodolac administrable par voie orale

Country Status (26)

Country Link
US (1) US5958445A (fr)
EP (1) EP0748628A3 (fr)
JP (1) JPH093071A (fr)
KR (1) KR970000228A (fr)
CN (1) CN1152434A (fr)
AR (1) AR003435A1 (fr)
AU (1) AU711853B2 (fr)
BR (1) BR9602758A (fr)
CA (1) CA2178686A1 (fr)
CO (1) CO4700456A1 (fr)
CZ (1) CZ170296A3 (fr)
EA (1) EA000047B1 (fr)
EE (1) EE9600067A (fr)
HU (1) HUP9601635A3 (fr)
IL (1) IL118636A (fr)
IN (1) IN182040B (fr)
MA (1) MA23907A1 (fr)
NO (1) NO962491L (fr)
NZ (1) NZ286791A (fr)
PE (1) PE10898A1 (fr)
PL (1) PL314732A1 (fr)
SG (1) SG46737A1 (fr)
SK (1) SK74396A3 (fr)
SV (1) SV1996000051A (fr)
TR (1) TR199600499A2 (fr)
ZA (1) ZA964928B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0974366B1 (fr) 1997-03-28 2006-10-18 Eisai Co., Ltd. Preparations pharmaceutiques orales dont on a reduit l'amertume au moyen d'un masquant
AU6589200A (en) * 1999-09-10 2001-04-17 Ranbaxy Laboratories Limited Extended release formulation of etodolac
WO2001021178A2 (fr) * 1999-09-22 2001-03-29 Akzo Nobel, N.V. Procede destine a traiter le syndrome de dysfonctionnement cognitif chez le chien et comprimes a croquer pour chiens
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
DE60139379D1 (de) * 2000-03-01 2009-09-10 Eisai R&D Man Co Ltd Schnellzerfallende polyvinylhaltige tablette
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
ES2265439T3 (es) * 2000-08-18 2007-02-16 Pharmacia Corporation Formulacion oral de valdecoxib que se desintegra rapidamente.
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
HUP0400098A2 (hu) * 2001-02-27 2004-04-28 Ranbaxy Laboratories Limited Gyorsan kioldódó ciklooxigenáz-2 enzimgátló hatóanyagot tartalmazó tabletták és eljárás az előállításukra
KR20040058189A (ko) * 2001-09-26 2004-07-03 파마시아 코포레이션 관능상 허용가능한 경구내 붕해 조성물
US20040137052A1 (en) * 2001-12-25 2004-07-15 Yoshihiro Uchiyama Acid-containing preparations
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
ES2372959T3 (es) * 2004-01-29 2012-01-30 Medrx Co., Ltd. Analgésico anti-inflamatorio para uso externo.
EP1744757A4 (fr) * 2004-05-04 2009-04-22 Equitech Corp Composition ains amelioree
BRPI0602825A2 (pt) * 2006-06-23 2012-04-24 Rhodia Br Ltda formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente
US20090258823A1 (en) * 2006-12-08 2009-10-15 George Caroline L S Composition and methods for the prevention and treatment of gastrointestinal infections
HUE041514T2 (hu) 2012-02-06 2019-05-28 Merial Inc Szisztémásan ható hatóanyagokat tartalmazó, parazitaellenes, szájon át adagolt állatgyógyászati készítmények, eljárások és alkalmazásuk
JP6088637B2 (ja) 2012-04-04 2017-03-01 インターベット インターナショナル ベー． フェー． イソオキサゾリン化合物のための固形経口医薬組成物
WO2013169218A1 (fr) * 2012-05-08 2013-11-14 Mahmut Bilgic Compositions pharmaceutiques de s-étodolac

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260148A (en) * 1939-06-19 1941-10-21 Frank H Fleer Corp Chewing gum material
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3939178A (en) * 1971-06-01 1976-02-17 American Home Products Corporation Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (fr) * 1977-07-20 1981-03-10 George K. E. Gregory Emballages
US4265847A (en) * 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
US4520203A (en) * 1983-08-16 1985-05-28 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
EP0267321B1 (fr) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Médicament contenant l'ibuprofen
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ATE193648T1 (de) * 1992-03-13 2000-06-15 Sepracor Inc Antipyretische und analgetische verfahren und zusammensetzungen, die optisch reines r-etodolac enthalten
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
IL118636A0 (en) 1996-10-16
HU9601635D0 (en) 1996-08-28
EP0748628A3 (fr) 1997-04-23
ZA964928B (en) 1997-12-10
KR970000228A (ko) 1997-01-21
EP0748628A2 (fr) 1996-12-18
NO962491D0 (no) 1996-06-12
HUP9601635A3 (en) 2000-06-28
CA2178686A1 (fr) 1996-12-14
TR199600499A2 (tr) 1996-12-21
SK74396A3 (en) 1997-04-09
US5958445A (en) 1999-09-28
SV1996000051A (es) 1997-02-17
EA199600029A3 (ru) 1997-03-31
JPH093071A (ja) 1997-01-07
EE9600067A (et) 1996-12-16
CN1152434A (zh) 1997-06-25
CZ170296A3 (en) 1997-04-16
AU5588096A (en) 1997-01-02
CO4700456A1 (es) 1998-12-29
AU711853B2 (en) 1999-10-21
NO962491L (no) 1996-12-16
AR003435A1 (es) 1998-08-05
NZ286791A (en) 1998-01-26
PE10898A1 (es) 1998-03-20
PL314732A1 (en) 1996-12-23
BR9602758A (pt) 1998-04-22
EA000047B1 (ru) 1998-04-30
IN182040B (fr) 1998-12-12
EA199600029A2 (ru) 1996-12-30
HUP9601635A2 (en) 1997-04-28
SG46737A1 (en) 1998-02-20
IL118636A (en) 2000-02-17

Similar Documents

Publication Publication Date Title
MA23907A1 (fr) Procede de fabrication de s(+) etodolac administrable par voie orale
MA23908A1 (fr) procede de fabrication des s(+) - ibuprofen administrable par voie orale
FR2744010B1 (fr) Procede de fabrication d'implants osseux
FR2777562B1 (fr) Procede de purification d'aminonitriles aliphatiques
DE69620107D1 (de) Kristallisationsverfahren
FR2701707B1 (fr) Procede pour la purification de lactide.
BR9709098A (pt) Produção de semente apomítica
FR2764883B1 (fr) Procede de fabrication d'hydrofluoroalcanes
FR2754816B1 (fr) Procede de purification d'hydrogenochlorofluoroethanes
EE9700353A (et) Protsess enantiomeerselt puhta asetidiin-2-karboksüülhappe saamiseks
FR2731701B1 (fr) Procede de fabrication de fluoroalcanes
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
FI980091A0 (fi) Menetelmä ylijäämäaktiivilietteen käsittelemiseksi
FR2753451B1 (fr) Procede de fabrication de d-erythrose
FR2799753B1 (fr) Procede perfectionne de fabrication d'anhydrides symetriques
FR2729387B1 (fr) Procede pour la fabrication d'hydroxy-alcoxy-benzophenones
NO973835D0 (no) Fremgangsmåte for fremstilling av lorakarbefmonohydrat
MA24015A1 (fr) Procede pour la preparation de dioxo-azabicyclohexanes
DE69632176D1 (de) Anti-inflammatorische Verbindungen
DE69612813T2 (de) Bildherstellungsverfahren
DE69614600T2 (de) Bilderzeugungsverfahren
FR2750998B1 (fr) Procede de preparation de k-carraghenase
FR2795847B1 (fr) Procede de perfectionnement de fabrication d'un insert
FR2732154B1 (fr) Procede de fabrication d'isolateurs
FR2733236B1 (fr) Procede de preparation de streptogramines